CogSpa-VR: Spatial Cognition Assessment in Virtual Reality

Sponsor
Université Paris Cité (Other)
Overall Status
Recruiting
CT.gov ID
NCT05723146
Collaborator
Hopitaux de Saint-Maurice (Other), Université Paris Saclay (Other)
60
1
1
29
2.1

Study Details

Study Description

Brief Summary

Unilateral spatial neglect (USN) is a highly-prevalent neuropsychological syndrome following a cerebral stroke characterized by massive impairments in daily life. The evaluation and the rehabilitation of USN encounter many limits whereas immersive virtual reality (VR) could be an efficient tool to go through these limits by imitating an environment of perception and action very close to the real one. The investigators will test a multisensory battery of evaluation based on VR for the diagnostic of USN.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Spatial cognition assessment
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Intervention Model Description:
60 patients with right stroke will be included in this study: a group of 30 patients with USN will be compared to a group of 30 patients without USN.60 patients with right stroke will be included in this study: a group of 30 patients with USN will be compared to a group of 30 patients without USN.
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
Spatial Cognition Assessment in Virtual Reality
Actual Study Start Date :
Jan 1, 2022
Actual Primary Completion Date :
Jan 1, 2023
Anticipated Study Completion Date :
Jun 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Experimental: Spatial cognition assessment

A single session of spatial cognition assessment (baseline) will be proposed to participants. This assessment will be based on paper-and-pencil tasks and immersive virtual reality tasks (with an HTC Vive Pro Head-Mounted-Display). The assessment will last around 1 hour.

Behavioral: Spatial cognition assessment
The intervention will be composed of tasks assessing spatial cognition in a real environment (cancellation task, line bisection and baking tray task) and in a virtual environment (cancellation task, line bisection, baking tray task and localization tasks).The Catherine Bergego Scale (questionnaire) will also be used.

Outcome Measures

Primary Outcome Measures

  1. Omissions in cancellation tasks [Baseline]

    Number and localization in space

  2. Deviation in line bisection tasks [Baseline]

    Deviation of the bisection from the true center of the lines (in mm)

  3. Number of the cubes in each side of space in the Baking Tray Tasks [Baseline]

    16 cubes have to be disposed

  4. Detections in the localization tasks [Baseline]

    Number and localization in space

Secondary Outcome Measures

  1. Duration of eye fixation in each side of space during VR tasks [Baseline]

    Collected thanks to the VR headset

  2. Completion time of each task [Baseline]

    (in s)

  3. Score in the Catherine Bergego Scale (CBS) [Assessed within the same week as Baseline]

    Functional assessment scored by the occupational therapists. Minimum: 0 / Maximum: 30 / Higher scores mean a better outcome

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • unilateral right stroke
Exclusion Criteria:
  • epilepsy / migraine

  • craniotomy

  • major sensory/motor deficit

  • severe cognitive impairment

Contacts and Locations

Locations

Site City State Country Postal Code
1 Université Paris Cité Paris France

Sponsors and Collaborators

  • Université Paris Cité
  • Hopitaux de Saint-Maurice
  • Université Paris Saclay

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Alma Guilbert, Associate Professor, Université Paris Cité
ClinicalTrials.gov Identifier:
NCT05723146
Other Study ID Numbers:
  • CogSpa-VR
First Posted:
Feb 10, 2023
Last Update Posted:
Feb 10, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Alma Guilbert, Associate Professor, Université Paris Cité
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 10, 2023